Loading clinical trials...
Loading clinical trials...
A Multicenter Prospective Observational Study on the Plasma Proteomic Profiling of Human and Microbial Proteins for the Early Identification of Biomarker Combinations (Combitypes) Associated With Complications in Oncohematologic Patients With Febrile Neutropenia
Conditions
Interventions
Plasma and DNA sample collection for proteomic and genomic analysis
Locations
3
Spain
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, Spain
Complejo Asistencial Universitario de Salamanca
Salamanca, Salamanca, Spain
Hospital Universitario Virgen Macarena
Seville, Sevilla, Spain
Start Date
May 15, 2026
Primary Completion Date
December 1, 2028
Completion Date
January 1, 2029
Last Updated
April 23, 2026
NCT06293677
NCT06787326
NCT04948463
NCT06254742
NCT06500715
NCT06665737
Lead Sponsor
Instituto de Investigación Biomédica de Salamanca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions